an R&D company in Lower Austria
OncoLab Diagnostics GmbH chose the TFZ-Wiener Neustadt as new location
13.01.2021 – Liquid Biopsy: One-stop-shop for identifying circulating tumor cells using PCR or immunostaining
13.01.2021 – Flüssigbiopsie: Alles aus einer Hand zum Aufspüren von zirkulierenden Tumorzellen mittels PCR und Immunfärbung
19.01.2021 – Transatlantic Partnership: Axon Dx announces Transatlantic Partnership for Commercialization of nCyteDx® Platform Suite: Blood-Based Biopsy Tools for Rare Cell Detection
22.09.2021 – p53 Prions – Novel Biomarker for Circulating Tumor Cells: Patent-pending Test Kit by OncoLab Launched
OncoLab is proud to present its full product range at the 5th ACTC – Advances in Circulating Tumor Cells meeting, 22nd-25th of September 2021, in Kalamata, Greece.
For a more detailed insight in our current work you may refer to the following documentations presented at the ACTC: